About ASH
Scientific Meetings
HTN Community Outreach
ASH Foundation Overview
Corporate Members
Related Organizations
Position Papers
ASH Home About Hypertension For Proffesionals For Patients HTN Specialist Membership
American Society of Hypertension (ASH) Members Log in
Make text larger
Home » Scientific Meetings » Scientific Awards » ASH Distinguished Scientist Award

ASH Distinguished Scientist Award

One ASH Distinguished Scientist Award is given each year depending on the field to which the award recipient has made his or her contribution. The purpose of the ASH Distinguished Scientist Award is to honor a scientist or physician for outstanding achievements in the field of hypertension. The award recipient receives a framed certificate and a $10,000 honorarium. The awardee is also requested to present a 30-minute lecture during the awards session at the ASH Annual Meeting and will receive complimentary registration and reimbursement for travel expenses and hotel accommodations.

Sponsors who wish to have their candidates nominated for an award must be current ASH members and provide the following information:

Complete name, address, phone, and fax numbers of the nominee
A signed letter of nomination from the sponsor and at least one additional supporting letter. The letters should clearly articulate the major contributions of the nominee to the field of hypertension.
A current curriculum vitae of candidate.

A candidate may be nominated by one or more different individuals within the same year. Previous winners of the ASH Distinguished Scientist Award and members of the ASH Scientific Awards Committee are not eligble for nomination.

The Awards Committee will assess the candidates' overall scientific contributions and their impact on the field of hypertension.

The ASH Distinguished Scientist Award recipient receives an award within one of these five categories:

William Harvey Award
This award is named for scientist William Harvey (1578- 1657) who developed the first accurate account of how the heart and circulatory system operated.

Richard Bright Award
This award is named for Richard Bright, (1789- 1858). Often referred to as the Father of Nephrology, Dr. Bright is well known for his great contributions to the study of the kidney.

Robert Tigerstedt Award
Robert Tigerstedt (1853- 1923) is recognized as an outstanding contributor to both endocrinology and circulation. He is best known for his discovery of the renin- angiotensin system.

Harriet Dustan Award
This award is named for Harriet P. Dustan, MD (1920 - 1999). Dr. Dustan made many contributions to hypertension in her career of over 40 years. These include her clinical and investigative achievements, especially the concept of essential hypertension as a multifactoral disease of pressure regulation. Dr. Dustan explored many of the pressor mechanisms and related new knowledge to therapeutic concepts.

Irvine Page Award
This award is named for Irvine H. Page, MD (1901 - 1991). In Dr. Page's long research career he made endless discoveries and contributions to the treatment and espousal of hypertension. He may be bast known for the discovery and characterization of angiotensin, the identification of serotonin, and the mosaic theory.

For more information, please contact:
Ashley Buron, Program Coordinator
American Society of Hypertension
45 Main Street, suite #712
Brooklyn, NY 11201
Phone: 212.696.9099
Fax: 347.916.0267
E-mail: awards@ash-us.org

2014 ASH Distinguished Scientist Award

The American Society of Hypertension announced the recipient of the ASH Harriet Dustan Award, Suzanne Oparil, MD, FASH. The 2014 Award was presented during the ASH Twenty-Ninth Annual Scientific Meeting during the Awards Plenary Session, which was held on Monday, May 19, 2014.

ASH Distinguished Scientist Award Recipient
Suzanne Oparil, MD, FASH

Dr. Oparil earned her medical degree at Columbia University College of Physicians and Surgeons, NY, completed her medical residency at Columbia Presbyterian Hospital and her cardiology fellowship at Massachusetts General Hospital.

Dr. Oparil is Past President of several prominent national societies: the American Federation for Medical Research (previously AFCR), the American Heart Association, and the American Society of Hypertension. She is a member of a number of prestigious societies, including the Association of American Physicians and the Institute of Medicine (IOM) of the National Academy of Sciences and has held many important advisory positions with the National Institutes of Health, including membership on task forces, advisory and peer review committees. She served as a Work Group Member of the Kidney Disease Improving Global Outcomes (KDIGO) Guideline for BP Management in Chronic Kidney Disease and Expert Panel Member for various national and international writing committees in hypertension research. Dr. Oparil served as Co-Chair of the Joint National Committee charged by NHLBI in 2008 with developing U.S. guidelines for the prevention, detection, evaluation, and treatment of high blood pressure. This groundbreaking guideline, recently published in JAMA (James PA, Oparil S, et al., J Am Med Assoc 2014), used rigorous evidence-based methodology and developed evidence statements and recommendations for blood pressure treatment based on a systematic review of available randomized controlled trials.

Dr. Oparil has received a number of honorary memberships, lectureships and distinguished awards for her contributions to hypertension research. These include the Lewis K. Dahl Memorial Lecture presented by the American Heart Association; the President's Achievement Award from the University of Alabama at Birmingham; the Consortium for Southeastern, Hypertension Control (COSEHC) Lifetime Achievement Award; and the Irving Page-Alva Bradley Lifetime Achievement Award, given alongside the '08 Harriet Dustan Award by the AHA Council for High Blood Pressure Research. More recent honors and awards include induction as Fellow of the American Society of Hypertension; the Virginia Frantz '22 Award for Distinguished Women in Medicine, presented by Columbia University College of Physicians and Surgeons; the Katz Visiting Professorship in Cardiovascular Research, presented by Columbia University Medical Center; the Distinguished Service Award for Recognition of Exceptional Leadership and Devoted Service to the Gulf Central Chapter of the American Society of Hypertension; the 2013 Distinguished Scientist Award (Translational Domain), given by the American College of Cardiology; election as Honorary Member to the Association of University Cardiologists by Council of the Association of University Cardiologists. Furthermore, as a testament to her exceptional accomplishments, Dr. Oparil was recently appointed by The Board of Trustees of the University of Alabama as Distinguished Professor in the Department of Medicine, Division of Cardiovascular Disease in the School of Medicine at the University of Alabama at Birmingham, with deepest appreciation for her distinguished service as Professor and innumerable contributions to the university. In addition, Dr. Oparil has been invited to deliver numerous distinguished lectures at prominent universities, including the Caroline Duncan Distinguished Woman in Medicine Visiting Professor, Louisiana State University SOM; the Carl Ludwig Distinguished Lecturer, Annual APS Meeting; the Jay N. Cohn Lecture at the University of Minnesota; the Fifth Annual Leslie Baer, M.D. '63 Memorial Lecture at Columbia University Medical Center; the Dr. Carlos Ferrario Founder Lecture presented at the Consortium for Southeastern Hypertension Control (COSEHC) Annual Scientific Sessions; the 9th Annual Distinguished Lectureship at Yale University Medical Center, sponsored by the Hypertension Foundation in honor of Dr. Marvin Moser; the Annual Russell Lectureship at the American College of Cardiology-Alabama Chapter Annual Meeting, jointly sponsored and co-provided by the American College of Cardiology Foundation; and the Tulane Health Sciences BIRCWH Distinguished Faculty Lecturer, Tulane University.

Dr. Oparil is a practicing cardiologist with a special interest in the fundamental mechanisms of cardiovascular disease and in applying information gained from her studies to the development of novel treatments. Her research ranges from molecular and cellular studies to whole animal studies to clinical trials. She has served as Principal Investigator of over 30 clinical research projects and has been continuously funded by the NIH for 30 years. Dr. Oparil directs basic and clinical programs in Vascular Biology and Hypertension. She has made many significant contributions to vascular biology and hypertension research and carries extensive expertise, evidenced by her impressive publication record (>725) on topics in clinical cardiology, atherosclerosis, heart failure, cardiovascular pathologies related to aging, vascular biology and hypertension.